Molecular staging of intracranial ependymoma in children and adults.
about
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysisThe Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research PerspectiveSpinal cord tumours: advances in genetics and their implications for treatmentMolecular genetics of ependymomaTelomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.A prognostic gene expression signature in infratentorial ependymoma.Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Genomic characterization of ependymomas reveals 6q loss as the most common aberrationDelineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis.Challenging issues in pediatric oncologyInfratentorial ependymomas--a study of the centre in KatowiceFusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.Molecular markers in pediatric neuro-oncology.Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study.Predictors of outcome in an AIEOP series of childhood ependymomas: a multifactorial analysisIntracranial ependymoma: long-term results in a series of 21 patients treated with stereotactic (125)iodine brachytherapy.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age GroupsAnalysis of the BRAF(V600E) Mutation in Central Nervous System Tumors.Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.Descriptive epidemiology of ependymal tumours in the United StatesChromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymomaThe role of CD133+ cells in a recurrent embryonal tumor with abundant neuropil and true rosettes (ETANTR).The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymomaRegion Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.Molecular diagnostics of gliomas: state of the art.Supratentorial ependymoma in children: to observe or to treat following gross total resection?Targets for therapy in ependymoma.Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomasSpinal cord ependymomas in children and adolescents.Current and evolving knowledge of prognostic factors for pediatric ependymomas.Emerging insights into the ependymoma epigenome.Ependymoma in children: molecular considerations and therapeutic insights.The molecular landscape of pediatric brain tumors in the next-generation sequencing era.Multidisciplinary management of pediatric intracranial ependymoma.
P2860
Q21136141-A86D14FA-F802-4D0B-8459-C6F3DE0F7FBBQ26766642-305A54B8-5C66-4A62-82F0-ED7002D50142Q26851596-D5AEF0F5-B63E-421D-8688-720BED30B2D0Q30438459-F97092FC-626E-4042-8E54-28D47D5D53FEQ30613404-758CD731-8F9C-47B8-B232-7A489ED07062Q33581494-AFAD2E42-D155-4D85-9385-AC7B47B9E645Q33634701-F3D65CA8-5949-4876-AEDD-EB4D7F0EA32CQ33803137-A28D1F5F-BC4D-4356-B099-80EAC558C7A3Q33881660-C2836165-35B1-4E21-A433-F0E13AF0A46EQ34132926-609D821C-F276-4933-84F7-24A74C3CEDB8Q34285237-4610B5C8-FC57-43FF-92B9-4707F3ACF09CQ35272294-2C3F733C-5134-4358-A037-EEE4DB93072AQ35602419-47051C97-266C-49B0-9DF1-B3E884E04175Q35825515-A947E380-DFB8-467D-A8E0-A3DC39EBF229Q36082481-52FAC72C-9E6C-4B2A-816F-F66D2D9E65B7Q36135966-6382DD26-76CB-44D5-977F-BDB0D88109AEQ36344704-794E0A68-6AD5-43E7-A16A-A1B2139DC159Q36344746-B90D4A02-6220-4799-B00D-3CFD71566937Q36344765-E6A8C560-E6F8-46D9-844F-A3C9AF9846C7Q36373774-A935C479-09E6-4192-A199-CE9B031858F5Q36461766-C50BA0DD-57F9-46CA-AB15-4A268F7C1362Q36525778-9A15EA46-119F-45AB-B198-70E27DECC8AAQ36560149-6A31BDD5-81C8-4772-8B36-40B432B33AEAQ36924756-C2230ABA-2286-4D59-9885-EB4395D165BEQ37196135-CA5B564B-DB33-4728-923C-13A08D2EE417Q37402364-DEC38886-A7AD-4006-87C3-8A553C9DFCF6Q37553466-74417F33-B998-4E51-A55F-55639240BBEDQ37641698-9B991C17-5BC5-4D77-BCA5-C634A8D576ADQ37705192-41A1AA26-D33F-423B-B9D7-A368F9FEB955Q37727557-57609CC7-0DEF-402F-90BC-72CCE60D1824Q37780495-A7F70508-0E07-43EC-B7C1-48C5A6B73CE9Q37849262-43468ACB-0BDD-429B-8EF6-27ECE4955771Q37858907-371956AF-CE9F-4AEB-8CFE-F3B5CBF87272Q38003799-37281070-AD8B-4740-93B4-8970589F5C9EQ38041984-999C372B-25FF-4F39-AA2C-F5B5B8F435E5Q38081982-2BD9788A-45E2-46C2-BA91-0AEE8774F7F5Q38083798-B4351BE2-3494-4265-AB74-EB7A0385650DQ38101501-A033ACAE-5962-4085-BB58-52ABDFBB4694Q38231122-9CFB2BE8-9483-4B73-92F1-EEBEFEDFFBF3Q38233102-14FB3039-8303-4382-86C3-2F1FC22127BB
P2860
Molecular staging of intracranial ependymoma in children and adults.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Molecular staging of intracranial ependymoma in children and adults.
@en
Molecular staging of intracranial ependymoma in children and adults.
@nl
type
label
Molecular staging of intracranial ependymoma in children and adults.
@en
Molecular staging of intracranial ependymoma in children and adults.
@nl
prefLabel
Molecular staging of intracranial ependymoma in children and adults.
@en
Molecular staging of intracranial ependymoma in children and adults.
@nl
P2093
P50
P356
P1476
Molecular staging of intracranial ependymoma in children and adults.
@en
P2093
Andrea Wittmann
Andreas E Kulozik
Andrey Korshunov
Anna Schöttler
Axel Benner
Hendrik Witt
Marina Ryzhova
Sebastian Bender
Thomas Hielscher
P304
P356
10.1200/JCO.2009.27.3359
P407
P577
2010-06-01T00:00:00Z